DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 138 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q1 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $5,000 | +66.7% | 600 | +35.7% | 0.00% | – |
| Q4 2019 | $3,000 | +50.0% | 442 | -9.1% | 0.00% | – |
| Q3 2019 | $2,000 | -50.0% | 486 | -14.3% | 0.00% | – |
| Q1 2019 | $4,000 | -42.9% | 567 | -18.1% | 0.00% | – |
| Q4 2018 | $7,000 | -87.0% | 692 | -72.3% | 0.00% | -100.0% |
| Q3 2017 | $54,000 | +671.4% | 2,500 | +257.1% | 0.01% | +400.0% |
| Q2 2017 | $7,000 | -97.3% | 700 | -93.5% | 0.00% | -97.5% |
| Q4 2015 | $261,000 | -18.2% | 10,805 | -16.9% | 0.04% | -13.0% |
| Q3 2015 | $319,000 | – | 13,005 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,415,000 | $105,945,000 | 12.42% |
| Chicago Capital, LLC | 5,842,906 | $73,562,000 | 4.06% |
| PFM Health Sciences, LP | 3,805,370 | $47,910,000 | 1.83% |
| Rhenman & Partners Asset Management AB | 800,000 | $10,072,000 | 1.14% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,320,000 | $29,209,000 | 0.71% |
| Rock Springs Capital Management LP | 1,681,458 | $21,170,000 | 0.62% |
| FEDERATED HERMES, INC. | 16,022,731 | $201,726,000 | 0.55% |
| FIRETHORN WEALTH PARTNERS, LLC | 47,376 | $665,000 | 0.54% |
| Jackson Creek Investment Advisors LLC | 82,435 | $1,185,000 | 0.48% |
| OBERWEIS ASSET MANAGEMENT INC/ | 137,200 | $1,727,000 | 0.44% |